Ostatní
Návod 
Johnson & Johnson
JNJ
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
451.2B
Obrat
94B
Zisk
27B
Aktiva
193B
Dluh
6B
ROE
0%
ROA
0%
PE
21
PS
6
Cena 1R
142-220
⌀ Cena
176.56
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
21-04-2026
Poslední dividenda
24-02-2026
Profil
Johnson & Johnson společně se svými dceřinými společnostmi zkoumá a vyvíjí, vyrábí a prodává různé produkty v oblasti zdravotní péče po celém světě. Spotřebitelský segment společnosti nabízí výrobky pro péči o dítě pod značkami JOHNSON'S a AVEENO Baby; přípravky pro péči o dutinu ústní pod značkou LISTERINE; přípravky pro péči o pleť/krásu pod značkou AVEENO, CLEAN & CLEAR, DR. Značky CI:LABO, NEUTROGENA a OGX; výrobky z tylenolacetaminofenu; přípravky ze studena, chřipky a alergií SUDAFED; přípravky z alergií BENADRYL a ZYRTEC; ibuprofenové výrobky MOTRIN IB; přípravky pro odvykání kouření NICORETTE a refluxní přípravky z kyseliny PEPCID. Nabízí také sociální vložky STAYFREE a CAREFREE, o.b. tampony, lepicí obvazy pod značkou BAND-AID a produkty první pomoci pod značkou NEOSPORIN. Slouží široké veřejnosti, maloobchodním prodejnám a distributorům. Farmaceutický segment společnosti nabízí produkty pro revmatoidní artritidu, psoriatickou artritidu, zánětlivé onemocnění střev a psoriázu; infekční onemocnění HIV/AIDS a COVID-19; poruchy nálady, neurodegenerativní poruchy a schizofrenie; rakovinu prostaty, hematologické maligní onemocnění, rakovinu plic a rakovinu močového měchýře; trombózu, diabetes a makulární degeneraci; a plicní arteriální hypertenzi. Tento segment přímo slouží prodejcům, velkoobchodníkům, distributorům, nemocnicím a zdravotnickým pracovníkům k předepisování léků. Jeho segment MedTech poskytuje elektrofyziologické produkty pro léčbu kardiovaskulárních onemocnění; přípravky pro neurovaskulární péči pro léčbu hemoragické a ischemické cévní mozkové příhody; ortopedické přípravky pro podporu kyčlí, kolene, traumatu, páteře, sportu a dalších; pokročilá a obecná chirurgická řešení zaměřená na estetiku prsu, ucha, nosu a krčních procedur; a jednorázové kontaktní čočky a oční přípravky pro operaci katarakty a laserové refrakce pod značkou ACUVUE. Tento segment slouží velkoobchodníkům, nemocnicím a maloobchodům. Společnost byla založena v roce 1886 a sídlí v New Brunswicku v New Jersey.
Sektor
Healthcare
Odvětví
Drug Manufacturers - General
Počet zaměstnanců
138100
Založení
1943-01-02
Podobné společnosti
$ 216.97
- $ 2.19
$ 126.72
+ $ 0.37
$ 45.70
+ $ 0.02
$ 86.23
- $ 0.05
$ 86.08
+ $ 1.50
$ 322.60
- $ 1.61
$ 24.16
- $ 0.28
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 94.19 | 94.19 | 88.82 | 85.16 | 94.94 | 93.78 | 82.58 | 82.06 | 81.58 | 76.45 | 71.89 | 70.07 | 74.33 | 71.31 | 67.22 | 65.03 | 61.59 | |
| Cost of Revenues | 25.64 | 25.64 | 27.47 | 26.55 | 31.09 | 29.86 | 28.43 | 27.56 | 27.09 | 25.35 | 21.69 | 21.54 | 22.75 | 22.34 | 21.66 | 20.36 | 18.79 | |
| Gross Profit | 68.56 | 68.56 | 61.35 | 58.61 | 63.85 | 63.92 | 54.16 | 54.50 | 54.49 | 51.10 | 50.21 | 48.54 | 51.59 | 48.97 | 45.57 | 44.67 | 42.80 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 24.56 | 23.99 | 23.74 | 21.89 | 22.52 | 22.47 | 22.45 | 21.38 | 21.40 | 21.35 | |
| Cost of Revenues | 3.35 | 7.30 | 7.63 | 7.36 | 7.13 | 6.96 | 6.87 | 6.51 | 6.80 | 6.61 | |
| Gross Profit | 21.22 | 16.69 | 16.12 | 14.54 | 15.39 | 15.51 | 15.58 | 14.87 | 14.60 | 14.75 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 15.05 | 15.39 | 14.71 | 12.16 | 11.36 | 10.78 | 10.55 | 9.10 | 9.05 | 8.49 | 8.18 | 7.67 | 7.55 | 6.84 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 20.11 | 24.77 | 24.66 | 22.08 | 22.18 | 22.54 | 21.42 | 19.95 | 21.20 | 21.95 | 21.83 | 20.87 | 20.97 | 19.42 | |
| Depreciation & Amortization | 7.27 | 7.32 | 7.34 | 7.49 | 6.97 | 7.39 | 7.23 | 7.01 | 6.93 | 5.64 | 3.75 | 3.75 | 3.90 | 4.10 | 3.67 | 3.16 | 2.94 | |
| Total Operating Expenses | 42.96 | 42.96 | 39.20 | 35.56 | 40.15 | 39.37 | 34.24 | 33.53 | 33.32 | 31.97 | 29.04 | 30.25 | 30.45 | 30.01 | 28.53 | 28.52 | 26.27 | |
| Operating Income | 25.60 | 25.60 | 22.15 | 23.41 | 23.92 | 24.42 | 19.82 | 21.01 | 20.78 | 18.57 | 20.81 | 17.87 | 20.67 | 18.55 | 16.56 | 15.67 | 16.18 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.48 | 3.45 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.51 | 5.10 | ||
| Depreciation & Amortization | 1.78 | 1.78 | 1.94 | 1.77 | 1.90 | 1.85 | 1.78 | 1.82 | 1.84 | 1.83 | ||
| Total Operating Expenses | 15.83 | 9.59 | 9.31 | 8.24 | 11.55 | 10.23 | 8.92 | 8.60 | 9.99 | 8.55 | ||
| Operating Income | 5.39 | 7.10 | 6.81 | 6.30 | 3.84 | 5.28 | 6.66 | 6.27 | 5.09 | 6.67 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.84 | 0.09 | 1.33 | 1.26 | 0.49 | 0.05 | 0.11 | 0.36 | 0.61 | 0.39 | 0.37 | 0.13 | 0.07 | 0.07 | 0.06 | 0.09 | 0.11 | |
| Interest Expense | 0.97 | 0.97 | 0.76 | 0.77 | 0.28 | 0.18 | 0.20 | 0.32 | 1.01 | 0.93 | 0.73 | 0.55 | 0.53 | 0.48 | 0.53 | 0.57 | 0.46 | |
| Other Expense | 6.99 | 6.99 | -5.46 | -8.35 | -2.19 | -1.64 | -3.33 | -3.68 | -2.78 | -0.90 | -1.00 | 1.33 | -0.11 | -3.08 | -2.79 | -3.31 | 0.77 | |
| IBT | 32.58 | 32.58 | 16.69 | 15.06 | 21.73 | 22.78 | 16.50 | 17.33 | 18.00 | 17.67 | 19.80 | 19.20 | 20.56 | 15.47 | 13.78 | 12.36 | 16.95 | |
| Income Tax Expense | 5.78 | 5.78 | 2.62 | 1.74 | 3.78 | 1.90 | 1.78 | 2.21 | 2.70 | 16.37 | 3.26 | 3.79 | 4.24 | 1.64 | 3.26 | 2.69 | 3.61 | |
| Net Income | 26.80 | 26.80 | 14.07 | 35.15 | 17.94 | 20.88 | 14.71 | 15.12 | 15.30 | 1.30 | 16.54 | 15.41 | 16.32 | 13.83 | 10.85 | 9.67 | 13.33 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.02 | 0.23 | 0.26 | 0.33 | 0.28 | 0.29 | 0.40 | 0.36 | 0.36 | 0.37 | ||
| Interest Expense | 0.44 | 0.02 | 0.31 | 0.20 | 0.14 | 0.19 | 0.27 | 0.16 | 0.15 | 0.19 | ||
| Other Expense | -0.43 | 0.40 | -0.32 | 7.33 | 0.05 | -1.94 | -0.91 | -2.56 | 0.22 | -0.98 | ||
| IBT | 4.97 | 7.49 | 6.49 | 13.63 | 3.89 | 3.34 | 5.75 | 3.71 | 4.83 | 5.22 | ||
| Income Tax Expense | -0.15 | 2.34 | 0.95 | 2.63 | 0.46 | 0.64 | 1.06 | 0.46 | 0.69 | 0.91 | ||
| Net Income | 5.12 | 5.15 | 5.54 | 11.00 | 3.43 | 2.69 | 4.69 | 3.26 | 4.05 | 26.03 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $13.88 | $6.83 | $7.93 | $5.59 | $5.74 | $5.75 | $0.48 | $6.08 | $5.57 | $5.86 | $4.90 | $3.91 | $3.54 | $4.86 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $13.73 | $6.73 | $7.81 | $5.51 | $5.63 | $5.61 | $0.47 | $5.93 | $5.48 | $5.70 | $4.81 | $3.86 | $3.49 | $4.78 | |
| Shares Outstanding | 2.43 | 2.43 | 2.41 | 2.53 | 2.63 | 2.63 | 2.63 | 2.63 | 2.66 | 2.68 | 2.71 | 2.76 | 2.78 | 2.82 | 2.78 | 2.72 | 2.74 | |
| Diluted Shares Outstanding | 2.44 | 2.43 | 2.43 | 2.56 | 2.66 | 2.67 | 2.67 | 2.68 | 2.73 | 2.75 | 2.79 | 2.81 | 2.86 | 2.88 | 2.81 | 2.78 | 2.79 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.68 | $10.32 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.67 | $10.21 | ||
| Shares Outstanding | 2.43 | 2.43 | 2.42 | 2.41 | 2.41 | 2.41 | 2.41 | 2.41 | 2.41 | 2.52 | ||
| Diluted Shares Outstanding | 2.44 | 2.43 | 2.42 | 2.42 | 2.43 | 2.43 | 2.42 | 2.43 | 2.43 | 2.55 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 24.88 | 24.11 | 21.86 | 14.13 | 14.49 | 13.99 | 17.31 | 18.11 | 17.82 | 18.97 | 13.73 | 14.52 | 20.93 | 14.91 | 24.54 | 19.36 | |
| Short Term Investments | 0.60 | 0.42 | 1.07 | 9.39 | 17.12 | 11.20 | 1.98 | 1.58 | 0.47 | 22.94 | 24.64 | 18.57 | 8.28 | 6.18 | 7.72 | 8.30 | |
| Total Cash & ST Investments | 25.48 | 24.52 | 22.93 | 23.52 | 31.61 | 25.19 | 19.29 | 19.69 | 18.30 | 41.91 | 38.38 | 33.09 | 29.21 | 21.09 | 32.26 | 27.66 | |
| Accounts Receivable | 15.79 | 18.93 | 14.87 | 16.16 | 15.28 | 13.58 | 14.48 | 14.10 | 13.49 | 11.70 | 10.73 | 10.99 | 11.71 | 11.31 | 10.58 | 9.77 | |
| Inventory | 12.17 | 12.44 | 11.18 | 12.48 | 10.39 | 9.34 | 9.02 | 8.60 | 8.77 | 8.14 | 8.05 | 8.18 | 7.88 | 7.50 | 6.29 | 5.38 | |
| Other Current Assets | 4.38 | 0.00 | 4.51 | 3.13 | 3.70 | 3.13 | 2.49 | 3.65 | 2.54 | 3.28 | 3.05 | 7.05 | 7.61 | 6.22 | 5.19 | 4.50 | |
| Total Current Assets | 57.82 | 55.89 | 53.50 | 55.29 | 60.98 | 51.24 | 45.27 | 46.03 | 43.09 | 65.03 | 60.21 | 59.31 | 56.41 | 46.12 | 54.32 | 47.31 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 18.23 | 18.58 | 38.47 | 24.11 | 19.98 | 24.88 | 25.47 | 21.86 | 19.73 | 21.18 | |
| Short Term Investments | 0.33 | 0.30 | 0.31 | 0.42 | 0.32 | 0.60 | 0.75 | 1.07 | 3.78 | 7.32 | |
| Total Cash & ST Investments | 18.56 | 18.88 | 38.78 | 24.52 | 20.30 | 25.48 | 26.22 | 22.93 | 23.51 | 28.51 | |
| Accounts Receivable | 17.61 | 17.85 | 16.02 | 18.93 | 16.17 | 15.79 | 14.95 | 14.87 | 14.80 | 16.78 | |
| Inventory | 14.15 | 13.41 | 12.66 | 12.44 | 12.60 | 12.17 | 11.38 | 11.18 | 11.20 | 12.89 | |
| Other Current Assets | 4.29 | 4.36 | 4.09 | 0.00 | 4.18 | 4.38 | 4.46 | 4.51 | 4.20 | 2.40 | |
| Total Current Assets | 54.61 | 54.50 | 71.55 | 55.89 | 53.25 | 57.82 | 57.00 | 53.50 | 53.70 | 60.57 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 19.75 | 20.52 | 19.90 | 19.80 | 18.96 | 18.77 | 17.66 | 17.04 | 17.01 | 15.91 | 15.91 | 16.13 | 16.71 | 16.10 | 14.74 | 14.55 | |
| Goodwill | 44.25 | 44.20 | 36.56 | 45.23 | 35.25 | 36.39 | 33.64 | 30.45 | 31.91 | 22.81 | 21.63 | 21.83 | 22.80 | 22.42 | 16.14 | 15.29 | |
| Intangible Assets | 39.73 | 37.62 | 34.18 | 48.33 | 46.39 | 53.40 | 47.64 | 47.61 | 53.23 | 26.88 | 25.76 | 27.22 | 27.95 | 28.75 | 18.14 | 16.72 | |
| Long-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long-Term Assets | 10.54 | 11.41 | 14.15 | 9.60 | 10.22 | 6.56 | 5.70 | -7.91 | 4.97 | 4.44 | 4.41 | 3.23 | 4.95 | 3.42 | 3.77 | 3.94 | |
| Total Long-Term Assets | 123.27 | 124.21 | 114.06 | 132.08 | 121.04 | 123.66 | 112.45 | 106.92 | 114.22 | 76.18 | 73.20 | 71.81 | 76.28 | 75.23 | 59.33 | 55.60 | |
| Total Assets | 181.09 | 180.10 | 167.56 | 187.38 | 182.02 | 174.89 | 157.73 | 152.95 | 157.30 | 141.21 | 133.41 | 131.12 | 132.68 | 121.35 | 113.64 | 102.91 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 53.38 | 21.95 | 20.87 | 20.52 | 20.48 | 19.75 | 19.63 | 19.90 | 18.82 | 20.58 | |
| Goodwill | 48.05 | 48.12 | 44.47 | 44.20 | 44.80 | 44.25 | 36.62 | 36.56 | 36.12 | 45.44 | |
| Intangible Assets | 48.74 | 49.84 | 36.76 | 37.62 | 39.49 | 39.73 | 34.29 | 34.18 | 35.02 | 46.25 | |
| Long-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long-Term Assets | -18.62 | 12.19 | 11.53 | 11.41 | 10.92 | 10.54 | 14.13 | 14.15 | 13.13 | 10.08 | |
| Total Long-Term Assets | 138.21 | 138.89 | 122.12 | 124.21 | 125.04 | 123.27 | 114.96 | 114.06 | 112.36 | 131.12 | |
| Total Assets | 192.82 | 193.39 | 193.67 | 180.10 | 178.29 | 181.09 | 171.97 | 167.56 | 166.06 | 191.69 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 8.85 | 10.31 | 9.63 | 11.70 | 11.06 | 9.51 | 8.54 | 7.54 | 7.31 | 6.92 | 6.67 | 7.63 | 6.27 | 5.83 | 5.73 | 5.62 | |
| Short-Term Debt | 9.86 | 5.98 | 3.45 | 12.77 | 3.77 | 2.63 | 1.20 | 2.80 | 3.91 | 4.68 | 7.00 | 3.64 | 4.85 | 4.68 | 6.66 | 7.62 | |
| Other Current Liabilities | 30.92 | 30.26 | 30.21 | 31.33 | 30.41 | 30.36 | 26.22 | 13.26 | 17.47 | 8.54 | 8.59 | 10.25 | 10.95 | 10.62 | 7.87 | 7.61 | |
| Current Liabilities | 53.93 | 50.32 | 46.28 | 55.80 | 45.23 | 42.49 | 35.96 | 31.23 | 30.54 | 26.29 | 27.75 | 25.09 | 25.68 | 24.26 | 22.81 | 23.07 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 9.63 | 9.46 | 9.55 | 10.31 | 8.95 | 8.85 | 8.17 | 9.63 | 8.36 | 10.44 | |
| Short-Term Debt | 6.39 | 11.53 | 13.90 | 5.98 | 4.46 | 9.86 | 8.55 | 3.45 | 3.87 | 11.70 | |
| Other Current Liabilities | 32.93 | 31.53 | 29.24 | 30.26 | 33.51 | 30.92 | 28.68 | 30.21 | 29.25 | 29.34 | |
| Current Liabilities | 50.87 | 54.18 | 56.90 | 50.32 | 51.76 | 53.93 | 48.73 | 46.28 | 44.37 | 54.17 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 31.64 | 31.85 | 26.98 | 26.89 | 29.99 | 32.64 | 26.49 | 27.68 | 30.68 | 22.44 | 12.86 | 15.12 | 13.33 | 11.49 | 12.97 | 9.16 | |
| Capital Leases | 0.00 | 1.20 | 1.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Def. Tax Liability | 2.64 | 2.45 | 3.19 | 6.37 | 7.49 | 7.21 | 5.96 | 7.51 | 8.37 | 2.91 | 2.56 | 3.15 | 3.99 | 3.14 | 1.80 | 1.45 | |
| Total Liabilities | 109.55 | 108.61 | 98.78 | 110.57 | 108.00 | 111.62 | 98.26 | 93.20 | 97.14 | 70.79 | 62.26 | 61.37 | 58.63 | 56.52 | 56.56 | 46.33 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.00 | 39.24 | 38.36 | 30.65 | 31.29 | 31.64 | 25.08 | 25.88 | 26.05 | 33.90 | |
| Capital Leases | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Def. Tax Liability | 5.99 | 3.80 | 2.43 | 2.45 | 2.95 | 2.64 | 3.17 | 3.19 | 2.62 | 3.63 | |
| Total Liabilities | 113.54 | 114.92 | 115.56 | 108.61 | 108.13 | 109.55 | 101.95 | 98.78 | 94.83 | 115.28 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | |
| Retained Earnings | 155.36 | 155.79 | 153.84 | 128.35 | 123.06 | 113.89 | 110.66 | 106.22 | 101.79 | 110.55 | 103.88 | 97.25 | 89.49 | 85.99 | 81.25 | 77.77 | |
| Comprehensive Income | -11.25 | -11.74 | -12.53 | -12.97 | -13.06 | -15.24 | -15.89 | -15.22 | -13.20 | -14.90 | -13.17 | -10.72 | -2.86 | -5.81 | -5.63 | -3.53 | |
| Total Common Equity | 71.54 | 71.49 | 68.77 | 76.80 | 74.02 | 63.28 | 59.47 | 59.75 | 60.16 | 70.42 | 71.15 | 69.75 | 74.05 | 64.83 | 57.08 | 56.58 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | |
| Retained Earnings | 167.28 | 165.37 | 162.64 | 155.79 | 155.18 | 155.36 | 153.38 | 153.84 | 152.54 | 129.38 | |
| Comprehensive Income | -15.24 | -14.31 | -11.74 | -11.74 | -12.52 | -11.25 | -10.77 | -12.53 | -8.78 | -13.14 | |
| Total Common Equity | 79.28 | 78.47 | 78.11 | 71.49 | 70.16 | 71.54 | 70.02 | 68.77 | 71.23 | 75.15 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 41.49 | 37.83 | 29.33 | 39.66 | 33.75 | 35.27 | 27.70 | 30.48 | 34.58 | 27.13 | 19.86 | 18.76 | 18.18 | 16.17 | 19.63 | 16.77 | |
| Book Value | 71.54 | 71.49 | 68.77 | 76.80 | 74.02 | 63.28 | 59.47 | 59.75 | 60.16 | 70.42 | 71.15 | 69.75 | 74.05 | 64.83 | 57.08 | 56.58 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.26 | |
| Book Value | 79.28 | 78.47 | 78.11 | 71.49 | 70.16 | 71.54 | 70.02 | 68.77 | 71.23 | 75.15 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 16.38 | 26.80 | 14.07 | 13.33 | 17.94 | 20.88 | 14.71 | 15.12 | 15.30 | 1.30 | 16.54 | 15.41 | 16.32 | 13.83 | 10.51 | 9.67 | 13.33 | |
| Depreciation & Amortization | 7.27 | 7.50 | 7.34 | 7.49 | 6.97 | 7.39 | 7.23 | 7.01 | 6.93 | 5.64 | 3.75 | 3.75 | 3.90 | 4.10 | 3.67 | 3.16 | 2.94 | |
| Stock-Based Compensation | 1.12 | 1.35 | 1.18 | 1.16 | 1.14 | 1.14 | 1.01 | 0.98 | 0.98 | 0.96 | 0.88 | 0.87 | 0.79 | 0.73 | 0.66 | 0.62 | 0.61 | |
| Change Working Capital | 1.86 | -12.72 | 1.84 | 2.51 | -4.01 | -4.24 | 2.69 | 3.87 | 0.00 | 11.24 | -1.77 | 1.34 | -1.07 | -0.94 | -1.97 | 1.65 | -0.87 | |
| Change In Accounts Receivable | -1.19 | -1.78 | -0.41 | -0.62 | -1.29 | -2.40 | 0.77 | -0.29 | -1.19 | -0.63 | -1.07 | -0.43 | -0.25 | -0.63 | -0.01 | -0.92 | -0.21 | |
| Change In Accounts Payable | 3.86 | 2.38 | 1.62 | 2.35 | 0.00 | 0.00 | 0.00 | 0.00 | -12.97 | 0.00 | -39.20 | -30.24 | -33.93 | -30.42 | -23.81 | 0.49 | 0.02 | |
| Change In Inventories | -1.32 | -1.45 | -1.13 | -1.32 | -2.53 | -1.25 | -0.27 | -0.28 | -0.64 | 0.58 | -0.25 | -0.45 | -1.12 | -0.62 | 0.00 | -0.72 | -0.20 | |
| Other Non-cash Items | 11.42 | 0.05 | 2.03 | 2.50 | 0.82 | 0.32 | -0.96 | -1.08 | 0.01 | -0.50 | -0.29 | -1.82 | -1.91 | 0.30 | 2.56 | 0.03 | 0.01 | |
| Cash from Operations | 24.64 | 0.00 | 0.00 | 22.79 | 21.19 | 23.41 | 23.54 | 23.42 | 22.20 | 21.06 | 18.77 | 19.28 | 18.47 | 17.41 | 15.40 | 14.30 | 16.39 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 5.12 | 5.15 | 5.54 | 11.00 | 3.43 | 2.69 | 4.69 | 3.26 | 4.13 | 4.31 | |
| Depreciation & Amortization | 2.01 | 1.78 | 1.94 | 1.77 | 1.90 | 1.85 | 1.78 | 1.82 | 1.84 | 1.83 | |
| Stock-Based Compensation | 0.31 | 0.35 | 0.41 | 0.29 | 0.24 | 0.30 | 0.34 | 0.30 | 0.18 | 0.30 | |
| Change Working Capital | -12.72 | 15.95 | -4.92 | -11.02 | 0.80 | 1.83 | -0.45 | -0.34 | 3.25 | -0.60 | |
| Change In Accounts Receivable | 0.39 | 0.11 | -1.36 | -0.93 | 0.85 | -0.10 | -0.88 | -0.28 | 0.23 | -0.25 | |
| Change In Accounts Payable | 1.27 | 2.00 | 1.24 | -2.13 | -1.09 | 2.26 | 2.93 | -2.48 | 1.68 | 1.73 | |
| Change In Inventories | -0.05 | -0.75 | -0.51 | -0.15 | -0.09 | -0.30 | -0.39 | -0.35 | 0.12 | -0.71 | |
| Other Non-cash Items | 16.27 | -16.27 | 0.08 | -0.03 | 0.64 | 1.24 | -0.03 | 0.19 | 0.88 | 1.10 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.86 | 7.49 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -4.34 | -4.83 | -4.42 | -4.54 | -4.01 | -3.65 | -3.35 | -3.50 | -3.67 | -3.28 | -3.23 | -3.46 | -3.71 | -3.60 | -2.93 | -2.89 | -2.38 | |
| Acquisitions | -13.99 | -17.54 | -15.15 | 0.00 | -17.65 | -0.06 | -7.32 | -5.81 | -0.90 | -35.15 | -4.51 | -0.95 | -2.13 | -0.84 | -4.49 | -2.80 | -1.27 | |
| Investments | -2.40 | -0.92 | -1.73 | -10.91 | -32.38 | -30.39 | -21.09 | -3.92 | -5.63 | -6.15 | -33.95 | -40.83 | -34.91 | -18.92 | -13.43 | -29.88 | -15.79 | |
| Sales of Investment | 9.22 | 1.66 | 2.46 | 19.39 | 41.61 | 25.01 | 12.14 | 3.73 | 4.29 | 28.12 | 35.78 | 34.15 | 24.12 | 18.06 | 14.80 | 30.40 | 11.10 | |
| Other Investing Activities | -1.30 | 0.00 | 0.00 | -3.06 | 0.07 | 0.42 | -1.20 | 3.31 | 2.74 | 1.60 | 1.14 | 3.36 | 4.33 | 0.19 | 1.55 | 0.56 | 0.49 | |
| Cash from Investing | -12.81 | 0.00 | 0.00 | 0.88 | -12.37 | -8.68 | -20.83 | -6.19 | -3.17 | -14.87 | -4.76 | -7.74 | -12.31 | -5.10 | -4.51 | -4.61 | -7.85 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.84 | -1.16 | -1.04 | -0.80 | -1.61 | -1.84 | -0.98 | -0.81 | -1.59 | -0.97 | |
| Acquisitions | -3.08 | 0.00 | -14.46 | 0.00 | 0.00 | -0.34 | -12.63 | -1.60 | 0.12 | 0.12 | |
| Investments | -0.24 | 2.44 | -2.86 | -0.25 | -0.26 | -0.28 | -0.55 | -0.63 | -0.93 | -0.29 | |
| Sales of Investment | 0.22 | 0.49 | 0.74 | 0.22 | 0.29 | 0.47 | 0.73 | 0.98 | 3.60 | 3.91 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.41 | -0.23 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.20 | 2.54 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -31.51 | 0.00 | 0.00 | -2.73 | -8.68 | -2.99 | -3.73 | -2.92 | -4.03 | -3.11 | -4.24 | -1.11 | -3.11 | -2.99 | -6.98 | -11.22 | -6.60 | |
| Debt Issued | 27.40 | 37.83 | 8.50 | -7.59 | 14.59 | 1.48 | 11.30 | 0.14 | -0.07 | 10.56 | 11.51 | 2.21 | 3.69 | 5.01 | 3.52 | 14.07 | 23.37 | |
| Issuance of Common Stock | 9.18 | 0.00 | 0.00 | 4.24 | 0.00 | 3.04 | 11.94 | 1.00 | 1.03 | 10.92 | 13.30 | 3.79 | 0.00 | 7.67 | 6.03 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -2.75 | -5.95 | -2.43 | -5.05 | -6.04 | -3.46 | -3.22 | -6.75 | -5.87 | -6.36 | -8.98 | -5.29 | -7.12 | -3.54 | -12.92 | -2.53 | -2.80 | |
| Dividends Paid | -11.59 | 0.00 | 0.00 | -11.77 | -11.68 | -11.03 | -10.48 | -9.92 | -9.49 | -8.94 | -8.62 | -8.17 | -7.77 | -7.29 | -6.61 | -6.16 | -5.80 | |
| Other Financing Activities | -1.11 | 0.00 | 0.00 | -0.51 | 17.53 | 0.40 | -0.63 | 0.58 | -0.15 | -0.19 | -0.02 | -0.06 | 5.74 | 0.06 | -0.08 | 15.45 | 10.22 | |
| Cash from Financing | -7.88 | 0.00 | 0.00 | -15.83 | -8.87 | -14.05 | -6.12 | -18.02 | -18.51 | -7.67 | -8.55 | -10.85 | -12.26 | -6.09 | -20.56 | -4.45 | -4.98 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.05 | -7.42 | |
| Debt Issued | 6.39 | -44.37 | -1.49 | 15.62 | 0.88 | -5.74 | 7.86 | 4.30 | 0.46 | -8.26 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -1.92 | 0.00 | 0.00 | -2.13 | -0.28 | -0.54 | -0.14 | -1.48 | -0.22 | -0.92 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.87 | -2.87 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.53 | -0.11 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4.66 | -11.32 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 3.70 | -4.40 | 2.25 | 7.73 | -0.36 | 0.50 | -3.32 | -0.80 | 0.28 | -1.15 | 5.24 | -0.79 | -6.40 | 6.02 | -9.63 | 5.19 | 3.55 | |
| Closing Cash Balance | 24.88 | 19.71 | 24.11 | 21.86 | 14.13 | 14.49 | 13.99 | 17.31 | 18.11 | 17.82 | 18.97 | 13.73 | 14.52 | 20.93 | 14.91 | 24.54 | 19.36 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 1.48 | -0.35 | -19.90 | 14.37 | 4.13 | -4.90 | -0.60 | 3.61 | 2.13 | -1.46 | |
| Closing Cash Balance | 19.71 | 18.23 | 18.58 | 38.47 | 24.11 | 19.98 | 24.88 | 25.47 | 21.86 | 19.73 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 20.30 | 19.70 | 19.84 | 18.25 | 17.19 | 19.76 | 20.19 | 19.92 | 18.53 | 17.78 | 15.54 | 15.82 | 14.76 | 13.82 | 12.46 | 11.41 | 14.00 | |
| Real Free Cash Flow | 19.19 | 18.34 | 18.67 | 17.09 | 16.05 | 18.62 | 19.18 | 18.94 | 17.55 | 16.82 | 14.66 | 14.94 | 13.97 | 13.09 | 11.80 | 10.78 | 13.39 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 5.47 | 8.38 | 2.48 | 3.37 | 4.84 | 5.71 | 4.66 | 2.85 | 6.27 | 6.52 | |
| Real Free Cash Flow | 5.16 | 8.03 | 2.07 | 3.08 | 4.60 | 5.42 | 4.32 | 2.55 | 6.10 | 6.23 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 21.4 | 36.3 | 86.1 |
| P/S | 6.1 | 4.4 | 578 |
| P/B | 7.2 | 4.8 | 582.9 |
| P/FCF | 31.3 | 22.1 | 10581.1 |
| Market cap | $451.2 | $378.9 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 17.5 % | 0 % |
| Debt to Income | 23.8 % | 308.1 % | 0 % |
| Debt to Free cash flow | 34.8 % | 61.5 % | 0 % |
| Interest expense percentage | 3.8 % | 2.9 % | 7 % |
| Current ratio | 1.1 | 1.7 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 33.8 % | 22.5 % | 0 % |
| ROA | 13.9 % | 10.3 % | 0 % |
| CapEx to Revenue | 5.1 % | 4.5 % | 10.5 % |
| RaD to Revenue | 0 % | 13.2 % | 0 % |
| ROEM | 682,063.7 | 441247.5 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 72.8 % | 68.2 % | 77.7 % |
| Operating margin | 27.2 % | 25.8 % | 29.4 % |
| Net margin | 28.5 % | 20.5 % | 22.3 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 2.7 % | 0 % |
| Dividend payout percentage | 0 % | 100.6 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 2,439.0 mil | 2,703.8 mil |
| Employee count | 138.1 tis | 115.7 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
